Literature DB >> 9375777

Should patients starting anticoagulant therapy be screened for missense mutations at Ala-10 in the factor IX propeptide?

J Peters, R Luddington, K Brown, C Baglin, T Baglin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9375777

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  2 in total

Review 1.  Life-threatening bleeding under vitamin K antagonists in spite of an INR in the therapeutic range.

Authors:  Mathilde Gavillet; Claire Abbal; Sabine Schmidt; Jasmine Nötzli; Jean-François Lambert; Anne Angelillo-Scherrer
Journal:  J Thromb Thrombolysis       Date:  2011-08       Impact factor: 2.300

Review 2.  Clinical utilization of the international normalized ratio (INR).

Authors:  R S Riley; D Rowe; L M Fisher
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.